Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Why Iovance Biotherapeutics Stock Was Climbing Today (Fool) +++ IOVANCE Aktie -3,21%

CROSS COUNTRY HEALTHCARE Aktie

 >Aktienkurs 
11.8 EUR    (Tradegate)
Ask: 11.9 EUR / 510 Stück
Bid: 11.7 EUR / 520 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
Aktie über LYNX handeln
>Performance
1 Woche: +8,3%
1 Monat: +7,3%
3 Monate: -4,8%
6 Monate: -31,8%
1 Jahr: -6,7%
laufendes Jahr: -31,6%
>CROSS COUNTRY HEALTHCARE Aktie
Name:  CROSS COUNTRY HEALTHCARE
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US2274831047 / 550897
Symbol/ Ticker:  XXY (Frankfurt) / CCRN (NASDAQ)
Kürzel:  FRA:XXY, ETR:XXY, XXY:GR, NASDAQ:CCRN
Index:  -
Webseite:  https://www.crosscountry...
Profil:  Cross Country Healthcare Inc. is a leading provide..
>Volltext..
Marktkapitalisierung:  380.49 Mio. EUR
Unternehmenswert:  314 Mio. EUR
Umsatz:  1021.38 Mio. EUR
EBITDA:  23.18 Mio. EUR
Nettogewinn:  -7.15 Mio. EUR
Gewinn je Aktie:  -0.22 EUR
Schulden:  2.37 Mio. EUR
Liquide Mittel:  69.54 Mio. EUR
Operativer Cashflow:  35.63 Mio. EUR
Bargeldquote:  0.84
Umsatzwachstum:  -31.16%
Gewinnwachstum:  -189.38%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  CROSS COUNTRY HEALTHCARE, CROSS COUNTRY HEALTH
Letzte Datenerhebung:  19.08.25
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 32.76 Mio. St.
Frei handelbar: 94.28%
Rückkaufquote: 3.67%
Mitarbeiter: 1400
Umsatz/Mitarb.: 0.82 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 41.69%
Bewertung:
KGV: -
KGV lG: 79.46
KUV: 0.37
KBV: 1.07
PEG-Ratio: -
EV/EBITDA: 13.55
Rentabilität:
Bruttomarge: 18.71%
Gewinnmarge: -0.7%
Operative Marge: 0.78%
Managementeffizenz:
Gesamtkaprendite: -1.44%
Eigenkaprendite: -1.96%
>Peer Group

Es sind 601 Aktien bekannt.
 
07.08.25 - 02:30
Cross Country Healthcare (CCRN) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
 
Cross Country (CCRN) delivered earnings and revenue surprises of -114.29% and -6.76%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...
06.08.25 - 23:48
Cross Country Healthcare Non-GAAP EPS of -$0.01 misses by $0.07, revenue of $274M misses by $18.19M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
31.07.25 - 18:28
Cross Country Healthcare gains on report it likely won′t be subject of FTC meeting (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.07.25 - 16:57
Cross Country Healthcare drops amid news of FTC meeting next week (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.05.25 - 22:18
Cross Country Healthcare Announces First Quarter 2025 Financial Results (Business Wire)
 
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2025. SELECTED FINANCIAL INFORMATION:       Variance Variance       Q1 2025 vs Q1 2025 vs Dollars are in thousands, except per share amounts Q1 2025 Q1 2024 Q4 2024 Revenue $ 293,408       (23 ) %   (5 ) % Gross profit margin*   20.0   %   (40 ) bps   —   bps Net loss attributable to common stockholders $ (490 )     (118 ) %   87   % Diluted EPS $ (0.02 )   $ (0.10 )   $ 0.10     Adjusted EBITDA* $ 8,619       (44 ) %   (7 ) % Adjusted EBITDA margin*   2.9   %   (110 ) bps   (10 ) bps Adjusted EPS* $ 0.06     $ (0.13 )   $ 0.02     Cash flows provided by operations $ 5,681       (5 ) %   (77 ) %   * Represents amounts that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP) and are referred to as non-GAAP measures. Please refer to the accompanying discussion b...
11.03.25 - 16:30
Are Investors Undervaluing Cross Country Healthcare (CCRN) Right Now? (Zacks)
 
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks....
06.03.25 - 18:06
Cross Country Healthcare falls on report about FTC review of Aya deal (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.03.25 - 01:00
Cross Country Healthcare (CCRN) Misses Q4 Earnings Estimates (Zacks)
 
Cross Country (CCRN) delivered earnings and revenue surprises of -63.64% and 1.22%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?...
05.03.25 - 23:21
Cross Country Healthcare Non-GAAP EPS of $0.04, revenue of $309.9M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.03.25 - 22:18
Cross Country Healthcare Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
 
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2024. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2024 Variance Q4 2024 vs Q4 2023 Variance Q4 2024 vs Q3 2024 Full Year 2024   Variance 2024 vs 2023 Revenue $ 309,940       (25 ) %   (2 ) % $ 1,344,004       (33 ) % Gross profit margin*   20.0   %   (190 ) bps   (40 ) bps   20.4   %   (190 ) bps Net loss attributable to common stockholders $ (3,753 )     (142 ) %   (247 ) % $ (14,556 )     (120 ) % Diluted EPS $ (0.12 )   $ (0.38 )   $ (0.20 )   $ (0.44 )   $ (2.49 )   Adjusted EBITDA* $ 9,271       (55 ) %   (10 ) % $ 49,073       (66 ) % Adjusted EBITDA margin*   3.0   %   (200 ) bps   (30 ) bps   3.7   %   (350 ) bps Adjusted EPS* $ 0.04     $ (0.25 )   $ (0.08 )   $ 0.46     $ (1.77 )   Cash flows provided by operations $ 24,2...
05.03.25 - 14:30
5 Broker-Loved Stocks to Keep an Eye on Amid Trade Tensions (Zacks)
 
Investors should monitor stocks like Cardinal Health, DXC Technology, Cross Country Healthcare, Avnet and Asbury for high returns....
28.02.25 - 23:42
Cross Country Healthcare shareholders OK acquisition by Aya (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.02.25 - 22:51
Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction (Business Wire)
 
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (“Cross Country” or the “Company”) (NASDAQ: CCRN) today announced that the Company has obtained all requisite stockholder approvals in connection with its proposed acquisition by Aya Healthcare. As previously disclosed, Cross Country and Aya Healthcare expect to complete the transaction in the second half of 2025, subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement. Upon completion of the transaction, Cross Country will become a private company and its common stock will no longer trade on the NASDAQ. Cross Country will file the final, certified voting results on a Form 8-K with the U.S. Securities and Exchange Commission. BofA Securities, Inc. is serving as financial advisor and Davis Polk & Wardwell LLP is serving as legal advisor to Cross Country. About Cross Country Healthcare Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm ...
21.02.25 - 23:27
Cross Country Healthcare/Aya get 2nd request from FTC on deal (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.02.25 - 12:00
Zacks Industry Outlook Highlights HireQuest, Heidrick & Struggles and Cross Country Healthcare (Zacks)
 
HireQuest, Heidrick & Struggles and Cross Country Healthcare have been highlighted in this Industry Outlook article....
28.01.25 - 06:01
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CCRN, LTRPA, OMC on Behalf of Shareholders (PR Newswire)
 
NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cross Country Healthcare, Inc. (NASDAQ:......
23.01.25 - 21:18
Cross Country Healthcare says HSR filing pulled/refiled in sale to Aya Healthcare (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.12.24 - 16:52
Cross Country Healthcare rises over 60% on $615 mln take-private deal (Reuters EN)
 
BUZZ-Cross Country Healthcare rises over 60% on $615 mln take-private deal ** Clinical services provider Cross Country Healthcare's CCRN.O shares rise 62.7% to $18.16 ** CCRN says peer Aya Healthcare will buy it in an all-cash deal for $18.61 per share, representing a total equity value of about $615 mln ** Aya and CCRN will continue to operate as separate brands, the companies say ** After deal, CCRN will become a private company ** The deal represents a premium of 66.8% to CCRN's closing price...
04.12.24 - 15:09
Cross Country Healthcare Agrees To Be Acquired By Aya Healthcare, Shareholders To Receive 67% Premium (Benzinga)
 
Cross Country Healthcare, Inc. shares are soaring premarket after agreeing to be acquired by Aya Healthcare for $18.61 per share in an all-cash deal valued at $615 million. The merger will expand Aya's services and create opportunities for employees. read more...
04.12.24 - 14:12
Cross Country Healthcare stock soars on acquisition by Aya Healthcare for $18.61/share (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Am Anfang war die Kraft. - Paula Modersohn-Becker
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!